Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06018857 · ClinicalTrials.gov registry record
Registry 17-009: Multi-Institutional Study Examining Patients With HCC Undergoing Liver Transplantation
A clinical trial of Hepatocellular Carcinoma, sponsored by Federico Aucejo.
- Active
- Registry status
- 1,000
- Enrollment target
- 2
- Study locations
NCT06018857 is a study of Hepatocellular Carcinoma that is active but no longer recruiting, run by Federico Aucejo. The registered enrollment target is 1,000 participants, above the 251-participant average among 145 other Hepatocellular Carcinoma trials with a reported enrollment target (298% higher). The trial reports 2 study locations across 1 state.
The verdict
NCT06018857, a study of Hepatocellular Carcinoma, is active but no longer recruiting, sponsored by Federico Aucejo.
- ACTIVE NOT RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a registry study examining patients with HCC undergoing liver transplantation including outcomes and predictors of recurrence
Conditions Studied
Study Locations (2)
Ohio
- Cleveland Clinic Foundation - Cleveland
- Ohio State University - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2017-05-11 |
| Est. Completion | 2028-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06018857
The ClinicalTrials.gov registry entry for NCT06018857 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 251-participant average among 145 other Hepatocellular Carcinoma trials with a reported enrollment target (298% higher). The listed sponsor is Federico Aucejo, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hepatocellular Carcinoma appearing as the primary indexed condition, and to 0 interventions.
NCT06018857 reports 2 study locations spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT06018857 about?
NCT06018857 is a clinical study titled "Registry 17-009: Multi-Institutional Study Examining Patients With HCC Undergoing Liver Transplantation". This is a registry study examining patients with HCC undergoing liver transplantation including outcomes and predictors of recurrence
What is the current status of trial NCT06018857?
This trial is currently active not recruiting. The enrollment target is 1,000 participants. The study started on 2017-05-11. Estimated completion is 2028-12.
What conditions does trial NCT06018857 study?
This clinical trial studies the following conditions: Hepatocellular Carcinoma.
Who is sponsoring clinical trial NCT06018857?
This trial is sponsored by Federico Aucejo, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06018857 being conducted?
This trial has 2 study locations across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hepatocellular Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Molecular Basis of Pediatric Liver Cancer
RECRUITING
-
Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
RECRUITING · Phase 2
-
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
RECRUITING · Phase 1
-
Targeted Navigation in Hepatocellular Carcinoma (HCC)
RECRUITING · NA
-
Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
RECRUITING · Phase 1
-
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.